Boston ivy

Other Names

amazuraAmpelopsis hoggiiAmpelopsis tricuspidataAmpelopsis veitchiiBoston creeperCissus thunbergiicitaCottage ivydamjaeng'ideongguldìjǐnDreilappige JungfernrebeDreilappiger Wilder WeinGrape ivyhóng pútáo téngJapanese creeperJapanese ivyjigeumjinishikinatsuzutapáqiánghǔParthenocissus thunbergiiParthenocissus tricuspidataParthenocissus veitchiipáshānhǔPsedera thunbergiiPsedera tricuspidataQuinaria tricuspidatatsutatǔgǔténgVigne Vierge De VeitchVitis inconstansVitis taquetiiVitis thunbergiiWoodbine

Synopsis

Boston Ivy (Parthenocissus tricuspidata): A Comprehensive Reference

1. Identity and Botanical Classification

Taxonomic Name and Synonyms

Parthenocissus tricuspidata is a species of flowering plant in the grape family (Vitaceae), native to eastern Asia (Korea, Japan, and northern and eastern China). Although unrelated to true ivy, it is commonly known as Boston ivy, grape ivy, Japanese ivy, and Japanese creeper. The genus name Parthenocissus is derived from the Greek words parthenos, meaning "virgin," and kissos, meaning "ivy," while the species epithet tricuspidata is derived from the Latin tri ("three") and cuspidatus ("pointed"), referring to the plant's characteristic three-lobed leaves.

Accepted botanical synonyms include Ampelopsis tricuspidata Sieb. & Zucc., Ampelopsis veitchii hort., Cissus thunbergii Siebold & Zucc., Parthenocissus thunbergii (Siebold & Zucc.) Nakai, Psedera thunbergii (Siebold & Zucc.) Nakai, Psedera tricuspidata (Siebold & Zucc.) Rehder, Quinaria tricuspidata (Siebold & Zucc.) Koehne, Vitis inconstans Miq., and Vitis taquetii.

Botanical Description

Parthenocissus tricuspidata is a deciduous climber growing to 18 m (59 ft) at a fast rate, flowering from July to August, with seeds ripening from October to November. The species is hermaphrodite, pollinated by insects. Boston ivy has dimorphic leaves: in its juvenile form the leaves are palmately compound with three leaflets, while in mature plants they become broadly ovate and prominently three-lobed, reaching 6–8 inches in length and 4–6 inches in width.

Natural Habitat and Geographic Distribution

The plant thrives in floodplain bushes, riverside woodland, and moist mountain mixed forests of eastern Asia. Scientifically known as Parthenocissus tricuspidata, it is native to China and Japan but has become popular in gardens and urban landscapes around the world.

Common Preparations and Supplement Forms

The sap of the plant is edible and flows freely when harvested in spring as the plant comes into new growth; it has traditionally been used as a sugar substitute. In the context of phytochemical and pharmacological research, preparations studied include methanol (MeOH) and ethyl acetate extracts of leaves, stems, and inflorescences; water extracts of stems for polysaccharide isolation; and centrifugal partition chromatography–purified isolates from stem material. Modern nutritional products sometimes incorporate Boston ivy extract alongside other nutrient-rich herbs, though today Boston ivy is more celebrated for its ornamental beauty. No standardized dietary supplement dosage form has been established in any reviewed pharmacopoeia or regulatory monograph.

2. Traditional and Historical Use

East Asian Folk Medicine

Parthenocissus tricuspidata is a woody vine native to East Asian countries such as Korea, China, and Japan, and has been used as a folk medicine for treating arthritis, jaundice, insect bites, and neuralgia. A number of stilbenes have been isolated and characterized from the plant and reported to possess diverse biological activities such as chemopreventive, hepatoprotective, antibacterial, and antifungal effects.

The leaves have been used as folk medicine in South Asia for treating arthritis, jaundice, insect bites, and neuralgia. These traditional indications appear consistently across published phytochemical research describing the plant's ethnobotanical context, though the specific historical texts or materia medica sources in which the plant is formally listed have not been identified in available peer-reviewed literature.

Japan: Culinary Sweetener Use

The sap of P. tricuspidata is used as a sweetener or sugar substitute in Japan. The sap is described in ethnobotanical databases as sweet, flowing freely when harvested in the spring as the plant comes into new growth, and usable as a sugar substitute.

Scope and Limitations of Traditional Use

In its native range, the vine has traditional medicinal uses in China and Korea and is used as a culinary sweetener in Japan. Both within and outside of East Asia, the plant is primarily used as an ornamental plant. There are no widely recognized medicinal uses for Boston ivy in modern medicine; historically, it has been most prominently used as a decorative plant. The gap between folk use in specific East Asian contexts and broader global medical recognition is significant: no formal regulatory monograph (e.g., European Medicines Agency, WHO Traditional Medicine monograph, German Commission E, or USP) for P. tricuspidata as a therapeutic agent has been identified in the current scientific literature.

3. Key Constituents and Active Compounds

Stilbenes and Stilbene Oligomers

Stilbenes represent the most thoroughly investigated class of compounds isolated from P. tricuspidata. Compounds such as caffeic acid, resveratrol, piceid, catechin, piceatannol, tricuspidatol A, pallidol, quadrangularins A, betulifol A, myrciaphenone A, and various stilbene dimers as well as glucosides have been reported as extracts from the Vitaceae family, including P. tricuspidata.

Centrifugal partition chromatography isolation from P. tricuspidata stems yielded five major compounds: aromadendrin-3-O-β-d-glucopyranoside, trans-piceid, catechin, resveratrol, and engeletin. Flavonoids and stilbenoids from P. tricuspidata were isolated in a single chromatographic run.

Tricuspidatol-A, a new resveratrol dimer (rel-2R,2′R-(4-hydroxyphenyl),3R,3′R-(3,5-dihydroxyphenyl) tetrahydrofuran), was isolated from the stemwood of P. tricuspidata, its structure established on the basis of spectroscopic evidence and biosynthetic considerations. An ethyl acetate fraction of a stem extract yielded two new stilbene dimers, parthenostilbenins A and B. These compounds were assessed for antioxidant activities in three different bioassay systems; among all isolates, piceatannol showed the strongest inhibitory activity, while parthenostilbenins A and B inhibited lipid peroxidation (IC₅₀ = 20.35 ± 1.22 and 18.68 ± 0.51 µg/mL, respectively) in a rat liver homogenate.

A new stilbene trimer, carasiphenol E, together with 13 known stilbenes, were isolated from the stems of P. tricuspidata, with chemical structure elucidated by spectroscopic and spectrometric data analyses and computational methods.

A novel stilbene glycoside, piceid-(1→6)-β-d-glucopyranoside, was isolated from the methanol extract of the leaves of P. tricuspidata together with four known compounds: piceid, resveratrol, longistylin A, and longistylin C; their structures were determined by 2D NMR spectroscopic and chemical analysis.

Phenolic Acids and Flavonoids

Parthenocissus tricuspidata has been regarded as a rich source of phenolic compounds. Previous phytochemical studies have confirmed this classification. Twelve phenolics were isolated from the stems of P. tricuspidata in bioassay-guided isolation, their structures elucidated by 1D and 2D NMR and MS data. These include caffeic acid and its derivatives; five caffeic acid derivatives were identified, including methyl ester of caffeoylglycolic acid, dimethyl ester of caffeoyltartaric acid, and dimethyl ester of caffeoyltartronic acid.

Kaempferol has been identified in P. tricuspidata specifically among Parthenocissus species, and this flavonoid, widely distributed within the Vitaceae family, exhibits radical scavenging activity and modulates inflammatory pathways by inhibiting NF-κB and reducing mediators such as iNOS and COX-2.

Polysaccharides

Four polysaccharides — PTP-1, PTP-2, PTP-3, and PTP-4 — were obtained from water extraction of the stems of P. tricuspidata by anion exchange chromatography and gel filtration. A water-soluble polysaccharide (PT2) was also isolated from the adhesive discs of P. tricuspidata, showing potential bio-adhesive properties.

Calcium Oxalate (Raphides)

The plant tissues contain calcium oxalate crystals (raphides), which are relevant to its safety profile (see Section 7). The sap within the leaves and stem contains raphides — needle-shaped crystals of calcium oxalate — which can puncture the skin, causing irritation and blisters similar to poison ivy in sensitive people.

4. Mechanisms of Action

Antioxidant Activity

Four polysaccharides from the stems of P. tricuspidata exhibited different antioxidant activities in vitro, with PTP-4 showing strong superoxide radical activity (comparable to BHT), high DPPH radical activity (78.53% at 1250 µg/mL), moderate hydroxyl radical scavenging activity, and reducing power activity. The chemical structure of PTP-4 was confirmed by FT-IR, GC, ¹H and ¹³C NMR spectra, indicating its main composition of arabinose, xylose, galactose, glucuronic acid, and mannose.

The highest DPPH-scavenging ability among tested extracts in one study was exhibited by methanol extracts of P. tricuspidata inflorescences, with IC₅₀ = 7.55 ± 0.07 µg/mL.

Structural oligomerization of stilbenes enhances π-electron delocalization and increases the number of accessible phenolic hydroxyl groups — properties associated with superior radical-scavenging and anti-inflammatory capacity relative to monomeric resveratrol.

Anti-inflammatory Mechanisms

At a concentration of 100 µg/mL, phenolic compounds isolated from P. tricuspidata stems showed potent anti-blood coagulation effects (compounds 2, 4, 6, and 10 with inhibitory percentages of 216, 174, 148, and 225%, respectively, versus 181% for aspirin used as a positive control). Anti-inflammatory activity was investigated in LPS-induced murine macrophage cells (RAW264.7); compounds 2, 4, and 6 potently inhibited nitric oxide production, with IC₅₀ values of 11.9 ± 0.3, 2.9 ± 0.2, and 29.0 ± 0.6 µM, respectively.

Kaempferol, identified in P. tricuspidata, modulates inflammatory pathways by inhibiting NF-κB and reducing mediators such as iNOS and COX-2. The broader anti-inflammatory profile associated with the Vitaceae family's polyphenols involves central molecular pathways such as NF-κB, NLRP3, MAPKs, eNOS, and Nrf2, thereby modulating oxidative stress and chronic inflammatory responses implicated in cardiovascular, metabolic, and neurodegenerative diseases.

Neuroprotective Mechanisms

All stilbene compounds (1–14) isolated from P. tricuspidata stems were assessed for their ability to inhibit nitric oxide (NO) production in LPS-activated murine microglia BV-2 cells and to stimulate nerve growth factor (NGF) production in C6 glioma cells. Compounds 2, 5, 6, and 10–12 inhibited NO production with IC₅₀ values ranging from 14.27 to 37.76 µM, while compounds 4 and 7 induced NGF secretion in C6 glioma cells (132.02 ± 7.55% and 128.15 ± 2.85%, respectively).

Resveratrol: Core Mechanisms

Resveratrol, one of the key stilbene monomers present in P. tricuspidata, has well-characterized mechanisms in the broader scientific literature. Resveratrol was found to act as an antioxidant and antimutagen and to induce phase II drug-metabolizing enzymes; it mediated anti-inflammatory effects and inhibited cyclooxygenase and hydroperoxidase functions (antipromotion activity), and induced human promyelocytic leukemia cell differentiation (antiprogression activity). These mechanisms, though studied in resveratrol from multiple plant sources, are relevant to the stilbene content of P. tricuspidata.

5. Scientific Evidence by Area of Use

5.1 Antioxidant Activity

The antioxidant activity of P. tricuspidata extracts has been investigated in several in vitro studies. Crude polysaccharides extracted from the stems exhibited strong antioxidant activity against DPPH radicals and moderate antioxidant diversity; four purified polysaccharides (PTP-1 to PTP-4) demonstrated different antioxidant profiles, with PTP-4 being particularly notable for its superoxide radical and DPPH radical scavenging activities.

Evidence strength: All published antioxidant data for P. tricuspidata specifically is derived from in vitro (cell-free or cell-based) assays. No human clinical trials evaluating the antioxidant capacity of Boston ivy extracts or preparations have been identified in the reviewed literature.

5.2 Anti-inflammatory and Antithrombotic Activity

Twelve phenolics isolated from the stems of P. tricuspidata were tested for antithrombotic activity and anti-inflammatory effects in LPS-induced murine macrophage cells; several compounds exceeded aspirin in anti-coagulation inhibition at the same concentration and potently inhibited nitric oxide production.

Evidence strength: Entirely preclinical; studies are in vitro using cell lines (RAW264.7 macrophages). No animal models or human trials have been reported specifically for P. tricuspidata anti-inflammatory effects.

5.3 Cytotoxic and Potential Anticancer Activity

Cyclohexane and methanol extracts of leaves and inflorescences of P. tricuspidata were shown to exert significant cytotoxic action on both estrogen-dependent (MDA-MB-361) and estrogen-independent (MDA-MB-453) breast cancer cell lines. Methanol extracts exhibited higher cytotoxicity for the MDA-MB-453 cell line (inflorescence: IC₅₀ = 111.45 ± 2.56 µg/mL; leaves: IC₅₀ = 56.76 ± 7.11 µg/mL).

Stilbenes from the plant have been reported to possess diverse biological activities such as chemopreventive, hepatoprotective, antibacterial, and antifungal effects.

Evidence strength: All cytotoxic data is in vitro only, conducted on cancer cell lines. There are no animal tumor models or human clinical trials. The IC₅₀ values reported are within a range typical of crude extracts and cannot be extrapolated to clinical efficacy.

5.4 Antiplasmodial Activity

A novel stilbene glycoside, piceid-(1→6)-β-d-glucopyranoside, isolated from the methanol extract of P. tricuspidata leaves, was tested in vitro against a chloroquine-sensitive strain of Plasmodium falciparum (D10). This compound had the most potent inhibition among isolated compounds, with an IC₅₀ value of 5.3 µM — the first reported antiplasmodial activity of a functional group position of stilbene from this species.

Evidence strength: Preliminary; single in vitro study. No in vivo or clinical validation exists for P. tricuspidata as an antimalarial agent.

5.5 Neuroprotective and Anti-neuroinflammatory Activity

All 14 isolated stilbene compounds from P. tricuspidata stems were assessed for the ability to inhibit NO production in LPS-activated murine microglia BV-2 cells and to produce NGF production in C6 glioma cells. Several compounds inhibited NO production with IC₅₀ values ranging from 14.27 to 37.76 µM, while two compounds induced NGF secretion in C6 glioma cells (132.02 ± 7.55% and 128.15 ± 2.85%).

Evidence strength: Preliminary in vitro data only. The induction of NGF in a glioma cell line is suggestive but cannot be interpreted as neuroprotective evidence in animals or humans. No in vivo studies specifically using P. tricuspidata extracts have been identified.

5.6 Antimicrobial Activity

Tested extracts of P. tricuspidata possessed weak antimicrobial activity in the study evaluating cytotoxic, antioxidant, and antimicrobial properties. The stilbenes and caffeic acid derivatives present in the plant have been noted in the broader Parthenocissus literature as contributing to antibacterial and antifungal effects, though specific minimum inhibitory concentration (MIC) data for P. tricuspidata is sparse in the reviewed sources.

Evidence strength: Very limited; described as "weak" in the primary comparative study.

5.7 Hepatoprotective Activity

Hepatoprotection is among the traditional indications for P. tricuspidata as a folk medicine in South Asia. Stilbenes from the plant have been reported to possess hepatoprotective effects in the literature surveying its biological activities. However, no published animal or human studies specifically evaluating hepatoprotective mechanisms using P. tricuspidata extracts or isolated compounds have been identified in the current systematic review of the literature.

Evidence strength: Claimed in traditional medicine context and cited qualitatively in phytochemical reviews, but no formal experimental hepatoprotective studies specific to this species have been verified.

6. Body Systems and Health Areas of Association

Musculoskeletal system: Traditional use for treating arthritis and neuralgia in Korea, China, and Japan.
Hepatobiliary system: Traditional folk medicine use for treating jaundice, suggesting a liver and biliary association.
Neurological system: In vitro evidence of stilbene-mediated inhibition of neuroinflammatory NO production in microglial cells and induction of nerve growth factor secretion in glioma cell models.
Cardiovascular and hematological system: Phenolics from stems exceeded aspirin in anti-blood coagulation assays in vitro, pointing to a potential hematological/cardiovascular association.
Immune system / inflammatory pathways: Polyphenols from Parthenocissus species act on central molecular pathways such as NF-κB, NLRP3, MAPKs, eNOS, and Nrf2, thereby modulating oxidative stress and chronic inflammatory responses.
Integumentary system (traditional): Traditional folk use includes treatment of insect bites, implying a topical or dermatological application.
Antiparasitic: In vitro antiplasmodial activity demonstrated against P. falciparum with an IC₅₀ of 5.3 µM for the most active stilbene glycoside.

7. Dosage Forms and Reported Dosages

No standardized human clinical dosage has been established for Boston ivy (P. tricuspidata) in any reviewed pharmacopeia or clinical trial. The following are dosage concentrations reported specifically in laboratory (in vitro) research studies:

Anti-blood coagulation assays tested phenolics at 100 µg/mL, where several compounds exceeded aspirin's activity.
Nitric oxide inhibition IC₅₀ values were 11.9 ± 0.3, 2.9 ± 0.2, and 29.0 ± 0.6 µM for specific phenolic isolates from stems.
Polysaccharide PTP-4 showed 78.53% DPPH radical scavenging activity at 1250 µg/mL.
Cytotoxicity against MDA-MB-453 breast cancer cells was observed with IC₅₀ values of 111.45 ± 2.56 µg/mL (inflorescence extract) and 56.76 ± 7.11 µg/mL (leaf extract).
The antiplasmodial stilbene glycoside from leaves demonstrated an IC₅₀ of 5.3 µM against Plasmodium falciparum in vitro.
Neuroinflammatory NO inhibition IC₅₀ ranged from 14.27 to 37.76 µM for active stilbene isolates; NGF induction reached 132.02 ± 7.55% and 128.15 ± 2.85% for two specific compounds in C6 glioma cells.
Parthenostilbenins A and B inhibited lipid peroxidation in a rat liver homogenate with IC₅₀ values of 20.35 ± 1.22 and 18.68 ± 0.51 µg/mL, respectively.

All concentrations above are derived from cell-free or cell-based laboratory assays and cannot be directly translated into human therapeutic dosages. No human pharmacokinetic data for Boston ivy–specific preparations has been identified in the reviewed literature.

8. Safety Considerations and Interactions

Calcium Oxalate (Raphides): Ingestion Hazard

The most significant safety concern for P. tricuspidata relates to its calcium oxalate content. Boston ivy (Parthenocissus tricuspidata) is botanically close to Virginia creeper and shares similar calcium oxalate content; toxicity profiles are nearly identical between the two species. The berries of related Parthenocissus species contain toxic amounts of oxalic acid and have been known to cause kidney damage in humans, while being non-toxic to birds.

The berries of P. tricuspidata are not edible for humans, and there are no known traditional uses of the leaves or other parts of the plant for tea or food. There are no widely recognized medicinal uses in modern or traditional medicine.

Contact Dermatitis: Raphide-Induced Skin Irritation

The plant's tissues and sap contain microscopic, irritating needle-like calcium oxalate crystals called raphides that can cause contact dermatitis (skin irritation and blisters) in sensitive people. The sap within the leaves and stem contains raphides that can puncture the skin, causing irritation and blisters similar to poison ivy in sensitive people, though the reactions are generally less severe than those of poison ivy. Importantly, P. tricuspidata does not produce urushiol, the allergenic compound responsible for poison ivy reactions.

Ocular Hazard

Splashes of plant tissue juice or the transfer of raphides from the hands to the eyes can cause immediate severe pain, lacrimation, and blepharospasm, as large numbers of calcium oxalate crystals penetrate the cornea. This hazard is relevant to handlers of the plant material in any preparation context.

Berry Toxicity in Quantity

The berries contain 2 or 3 seeds and are inedible to humans (and toxic when ingested in quantity). Because of their high concentration of oxalic acid they are moderately toxic to most mammals, including humans.

Antithrombotic Interaction Potential

Phenolic compounds isolated from P. tricuspidata stems exceeded aspirin in anti-blood coagulation activity at 100 µg/mL in vitro. While this is preclinical data only, the potency of these effects suggests that any future human use of concentrated extracts would theoretically warrant consideration of interactions with anticoagulant or antiplatelet medications. This has not been evaluated in any clinical or pharmacokinetic study.

Absence of Formal Regulatory Review

Boston ivy has not been evaluated by the European Medicines Agency (EMA), the U.S. Food and Drug Administration, the National Center for Complementary and Integrative Health (NCCIH), or in any WHO traditional medicine monograph as a therapeutic agent. No toxicology studies (acute, subacute, or chronic) specifically for P. tricuspidata extracts in humans or animals were identified in the reviewed peer-reviewed literature. The overall safety profile in a supplemental context is therefore essentially unstudied.

References

Health Conditions

Health conditions that Boston ivy may help support.

No conditions available.

Body Systems

Body systems that Boston ivy may help support.

No body systems available.